The CMT1A duplication and HNPP deletion

Genomic Disorders: The Genomic Basis of Disease

Volumn , Issue , 2006, Pages 169-178

  Timmerman, Vincent ^a   Lupski, James R ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955983862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-039-3_11     Document Type: Chapter

References (75)

1. Lupski JR, Garcia A. Charcot-Marie-Tooth peripheral neuropathies and related disorders. In: The Metabolic and Molecular Bases of Inherited Diseases (Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, Childs B, eds.) New York, NY: McGraw-Hill, 2001; pp. 5759-5788.
2. Shy ME, Lupski JR, Chance PF, Klein CJ, Dyck PJ. Hereditary motor and sensory neuropathies. In: Peripheral Neuropathy (Dyck PJ, Thomas PK, eds.) Philadelphia, PA: Elisevier Science, 2005; pp. 1623-1658.
3. Raeymaekers P, Timmerman V, Nelis E, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991;1:93-97.
4. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
5. Nicholson GA, Kennerson ML, Keats BJ, et al. Charcot-Marie-Tooth neuropathy type 1A mutation: apparent crossovers with D17S122 are due to a duplication. Am J Med Genet 1992;44:455-460.
6. Hallam PJ, Harding AE, Berciano J, Barker DF, Malcolm S. Duplication of part of chromosome 17 is commonly associated with hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease type 1). Ann Neurol 1992;31:570-572.
7. Hertz JM, Borglum AD, Brandt CA, Flint T, Bisgaard C. Charcot-Marie-Tooth disease type 1A: the parental origin of a de novo 17p11.2-p12 duplication. Clin Genet 1994;46:291-294.
8. Brice A, Ravise N, Stevanin G, et al. Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group. J Med Genet 1992;29:807-812.
9. Bellone E, Mandich P, Mancardi GL, et al. Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. J Med Genet 1992;29:492-493.
10. Guzzetta V, Santoro L, Gasparo-Rippa P, et al. Charcot-Marie-Tooth disease: molecular characterization of patients from central and southern Italy. Clin Genet 1995;47:27-32.
11. Holmberg BH, Holmgren G, Nelis E, van Broeckhoven C, Westerberg B. Charcot-Marie-Tooth disease in northern Sweden: pedigree analysis and the presence of the duplication in chromosome 17p11.2. J Med Genet 1994;31:435-441.
12. Ohnishi A, Li LY, Fukushima Y, et al. Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploidy. Am J Med Genet 1995;59:51-58.
13. Nelis E, Van Broeckhoven C, De Jonghe P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996;4:25-33.
14. Wise CA, Garcia CA, Davis SN, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993;53:853-863.
15. Hoogendijk JE, Hensels GW, Gabreels-Festen AA, et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 1992;339:1081-1082.
16. Mancardi GL, Uccelli A, Bellone E, et al. 17p11.2 duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur Neurol 1994;34:135-139.
17. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58:472-476.
18. Bort S, Martinez F, Palau F. Prevalence and parental origin of de novo 1.5-Mb duplication in Charcot-Marie-Tooth disease type 1A. Am J Hum Genet 1997;60:230-233.
19. Palau F, Lofgren A, De Jonghe P, et al. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet 1993;2:2031-2035.
20. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski J.R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 1992;2:292-300.
21. Kiyosawa H, Chance PF. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 1996;5:745-753.
22. Boerkoel CF, Inoue K, Reiter LT, Warner LE, Lupski J.R. Molecular mechanisms for CMT1A duplication and HNPP deletion. Ann N Y Acad Sci 1999;883:22-35.
23. Reiter LT, Murakami T, Koeuth T, Gibbs RA, Lupski J.R. The human COX10 gene is disrupted during homologous recombination between the 24 kb proximal and distal CMT1A-REPs. Hum Mol Genet 1997;6:1595-1603.
24. Stankiewicz P, Lupski J.R. Molecular-evolutionary mechanisms for genomic disorders. Curr Opin Genet Dev 2002;12:312-319.
25. Murakami T, Reiter LT, Lupski J.R. Genomic structure and expression of the human heme A:farnesyltransferase (COX10) gene. Genomics 1997;42:161-164.
26. Kennerson ML, Nassif NT, Dawkins JL, DeKroon RM, Yang JG, Nicholson GA. The Charcot-Marie-Tooth binary repeat contains a gene transcribed from the opposite strand of a partially duplicated region of the COX10 gene. Genomics 1997;46:61-69.
27. Inoue K, Dewar K, Katsanis N, et al. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001;11:1018-1033.
28. Inoue K, Lupski J.R. Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 2002;3:199-242.
29. Eichler EE. Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet 2001;17:661-669.
30. Valentijn LJ, Bolhuis PA, Zorn I, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:166-170.
31. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-151.
32. Roa BB, Garcia CA, Pentao L, et al. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet 1993;5:189-194.
33. Chance PF, Abbas N, Lensch MW, et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994;3:223-228.
34. Lupski J.R. 2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture. Am J Hum Genet 2003;72:246-252.
35. Reiter LT, Murakami T, Koeuth T, et al. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996;12:288-297.
36. Kiyosawa H, Lensch MW, Chance PF. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet 1995;4:2327-2334.
37. Timmerman V, Rautenstrauss B, Reiter LT, et al. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent. J Med Genet 1997;34:43-49.
38. Lopes J, LeGuern E, Gouider R, et al. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group. Am J Hum Genet 1996;58:1223-1230.
39. Yamamoto M, Yasuda T, Hayasaka K, et al. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum Genet 1997;99:151-154.
40. Chang JG, Jong YJ, Wang WP, et al. Rapid detection of a recombinant hotspot associated with Charcot-Marie-Tooth disease type IA duplication by a PCR-based DNA test. Clin Chem 1998;44:270-274.
41. Lupski J.R. Homologous recombination hotspots in the human genome-not all homolgous sequences are equal. Genome Biology 2004;5:242.
42. Reiter LT, Hastings PJ, Nelis E, De Jonghe P, Van Broeckhoven C, Lupski J.R. Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet 1998;62:1023-1033.
43. Lopes J, Tardieu S, Silander K, et al. Homologous DNA exchanges in humans can be explained by the yeast double-strand break repair model: a study of 17p11.2 rearrangements associated with CMT1A and HNPP. Hum Mol Genet 1999;8:2285-2292.
44. Matise TC, Chakravarti A, Patel PI, et al. Detection of tandem duplications and implications for linkage analysis. Am J Hum Genet 1994;54:1110-1121.
45. Lupski JR, Wise CA, Kuwano A, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:29-33.
46. Matsunami N, Smith B, Ballard L, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992;1:176-179.
47. Patel PI, Roa BB, Welcher AA, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:159-165.
48. Timmerman V, Nelis E, Van Hul W, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1:171-175.
49. Valentijn LJ, Baas F, Zorn I, Hensels GW, de Visser M, Bolhuis PA. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 1993;2:2143-2146.
50. van de Wetering RA, Gabreels-Festen AA, Timmerman V, Padberg GM, Gabreels FJ, Mariman EC. Hereditary neuropathy with liability to pressure palsies with a small deletion interrupting the PMP22 gene. Neuromuscul Disord 2002;12:651-655.
51. Lupski J.R. Charcot-Marie-Tooth disease: a gene-dosage effect. Hosp Pract (Off Ed) 1997:32-85.
52. Yoshikawa H, Nishimura T, Nakatsuji Y, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450.
53. Hanemann CO, Stoll G, D'Urso D, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994;37:654-659.
54. Hanemann CO, Stoll G, Muller HW. PMP22 expression in CMT1a neuropathy. Ann Neurol 1995;37:136.
55. Kamholz J, Shy M, Scherer S. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;36: 451-452.
56. Schenone A, Nobbio L, Mandich P, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997;48:445-449.
57. Schenone A, Nobbio L, Caponnetto C, et al. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies. Ann Neurol 1997;42:866-872.
58. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997;49:1635-1640.
59. Vallat JM, Sindou P, Preux PM, et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996;39:813-817.
60. Huxley C, Passage E, Manson A, et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996;5:563-569.
61. Magyar JP, Martini R, Ruelicke T, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996;16:5351-5360.
62. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16:1049-1060.
63. Huxley C, Passage E, Robertson AM, et al. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 1998;7:449-458.
64. Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 1997;17: 4662-4671.
65. Maycox PR, Ortuno D, Burrola P, et al. A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies. Mol Cell Neurosci 1997;8:405-416.
66. Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003;9:1533-1537.
67. Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004;10:396-401.
68. De Jonghe P, Timmerman V. Anti-steroid takes aim at neuropathy. Nat Med 2003;9:1457-1458.
69. Badano JL, Inoue K, Katsanis N, Lupski J.R. New polymorphic short tandem repeats for PCR-based Charcot-Marie-Tooth disease type 1A duplication diagnosis. Clin Chem 2001;47:838-843.
70. Kovach MJ, Lin JP, Boyadjiev S, et al. A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 1999;64:1580-1593.
71. Liehr T, Rautenstrauss B, Grehl H, et al. Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion. Hum Genet 1996;98:22-28.
72. Lupski J.R. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 1998;14:417-422.
73. Stankiewicz P, Lupski J.R. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002;18:74-82.
74. Patel PI, Lupski J.R. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 1994;10:128-133.
75. Rautenstrauss B, Fuchs C, Liehr T, Grehl H, Murakami T, Lupski J.R. Visualization of the CMT1A duplication and HNPP deletion by FISH on stretched chromosome fibers. J Peripher Nerv Syst 1997;2:319-322.